已收盘 08-01 16:00:00 美东时间
-0.040
-2.68%
<p>Alector, a clinical-stage biotech company focused on neurodegenerative diseases, announced a conference call on August 7, 2025, at 4:30 p.m. ET, to discuss Q2 2025 results and mid-year updates. A press release will be issued prior to the call, and a webcast will be available under the investor relations section of Alector’s website. Participants can register online to join by phone. Ryan Darby, MD, will discuss the unmet need in frontotemporal...
07-31 20:05
Alector (NASDAQ:ALEC) was surging after Mizuho Securities upgraded the biotechnology stock, citing "high risk/higher-reward bet". Shares were +9.09% during morning trade to $1.92. "Investing in the ne...
07-28 22:46
Mizuho analyst Graig Suvannavejh upgrades Alector (NASDAQ:ALEC) from Neutral to Outperform and raises the price target from $2.5 to $3.5.
07-28 19:08
Kyverna Therapeutics (NASDAQ:KYTX) announced on Monday the appointment of Marc Grasso as its chief financial officer (CFO), effective today. Most recently, Grasso served as CFO of Alector, a clinical...
06-30 21:32
Alector (NASDAQ:ALEC) announced on Friday that Marc Grasso, chief financial officer (CFO) of the company, will conclude his tenure effective June 20, 2025, to pursue other opportunities. Neil Berkley,...
06-14 04:15
-- Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D., effective June 20, 2025 --SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC),
06-14 04:06
Alector Inc - Appoints Neil Berkley as Interim CFO Effective June 20, 2025
06-14 04:05
<p>Alector announced Marc Grasso, M.D., will step down as CFO effective June 20, 2025. Neil Berkley, M.B.A., Chief Business Officer, will serve as Interim CFO while continuing his current role. Grasso joined the company in February 2022 and played a key role in strengthening the financial position. Berkley, with over two decades of experience in corporate and business development, is well-positioned to lead the transition. Alector remains focused...
06-13 20:05
Alector, Inc. announced that its management will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 10, 2024. The event will be available live and via replay on the company's website. Alector, a biotech company focused on neurodegenerative diseases, is developing therapies to combat diseases like Alzheimer's and Parkinson's, and advancing a proprietary drug delivery platform, Alector Brain Carrier (ABC), to e...
06-03 12:00